Skip to main content
. 2008 Oct 3;74(23):7197–7203. doi: 10.1128/AEM.00888-08

TABLE 1.

PCR oligonucleotides used in this study

Primer Specificity Amplicon size Nucleotide sequence (5′-3′)a
KshAType-F kshA homologue 0.3 kb TGYCCITTCCAYGAYTGGCGITGGGGIGG
KshAType-R kshA homologue TGIACGTAAAGAAGRTGIGCCATRTC
KshA2-F kshA2, kshA3 0.6 kb CTCGATGCCTACTGCCGTCAC
KshA2-R kshA2, kshA3 CGGATAGTGGCAGTTGATCAAAAC
KSHA2EX-F kshA2 1,167 bp GGCCATATGTTGACCACAGACGTGACGACC (NdeI)
KSHA2EX-R GCCACTAGTTCACTGCGCTGCTCCTGCACG (SpeI)
RT-KSHA2-F kshA2 469 bp AGCCAGAGCGAATTGAAGGT
RT-KSHA2-R ATGTCGTCGCGGTTGATACC
RT-KSTD1-F kstD1 489 bp CCAGGTGCAGGAACGCGCCG
RT-KSTD1-R CGCCTTGATTCGCTGGGTTT
16SRNA-RHODO-F 16S rRNA 427 bp GTCTAATACCGGATATGACCTC
16SRNA-RHODO-R R. erythropolis (4) GCAAGCNAGNAGTTGAGCTGCTGGT
delKSHA2-R Upstream kshA2 NAb TCGAATACTGGGGACACGAAGC
BLF bla 809 bp GCGCATATGCACCCAGAAACGCTGGTGAAAG (NdeI)
BLR GCGACTAGTTACCAATGCTTAATCAGTGAGGC (SpeI)
a

I, inosine; Y, C+T; R, A+G; N, any base. Underlined nucleotide sequences indicate incorporated restriction sites.

b

NA, not applicable.